RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pharmagreen Biotech Stock

Pharmagreen Biotech ROCE 2025

Pharmagreen Biotech ROCE

0.22

Ticker

PHBI

ISIN

US71716C1099

WKN

A2NB5X

In 2025, Pharmagreen Biotech's return on capital employed (ROCE) was 0.22, a -63.14% increase from the 0.6 ROCE in the previous year.

Pharmagreen Biotech Aktienanalyse

What does Pharmagreen Biotech do?

Pharmagreen Biotech Inc is a Canadian company specializing in the production of cannabis plants. The company was founded in 2009. Initially, the company focused primarily on research in the field of plant biotechnology. It worked on developing plants with higher cold resistance for cultivation in colder regions. Research in breeding plants with higher nutritional value was also part of their focus. In 2017, the company recognized the incredible potential of the cannabis industry and decided to apply its expertise in this field. Pharmagreen Biotech Inc began large-scale production of cannabis plants, working closely with other industry leaders to optimize production and create the best possible conditions. Pharmagreen Biotech Inc places great importance on sustainability and environmental awareness. All production methods are designed with ecological sustainability in mind. The plants are grown in environmentally-friendly greenhouses and all waste is recycled and reused. The business model of Pharmagreen Biotech Inc is tailored to the needs of its customers. The company produces cannabis plants for the medical and recreational sectors. It offers various types of plants to meet the needs of customers, including plants for home cultivation to cater to the growing market for self-grown cannabis plants. Products offered by Pharmagreen Biotech Inc also include seeds, fertilizers, and specialized cultivation kits tailored to the needs of cannabis plants. The company works closely with laboratories and research institutions to maximize and optimize the quality and potency of its products. The company recently developed a new technology called "Speed Breeding," which allows for the rapid breeding of cannabis plants. This enables Pharmagreen Biotech Inc to serve an even larger portion of the market and provide faster availability of products for customers. Pharmagreen Biotech Inc is divided into various divisions, including medical cannabis production, recreational cannabis, plant products, and seed production. Each division is led by a specialized team focused on the needs and requirements of customers in that area. Overall, Pharmagreen Biotech Inc is an innovative and sustainable company focused on the needs of its customers. Its wide range of products and ongoing research and development make it an important player in the rapidly growing cannabis industry. Pharmagreen Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Pharmagreen Biotech's Return on Capital Employed (ROCE)

Pharmagreen Biotech's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Pharmagreen Biotech's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Pharmagreen Biotech's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Pharmagreen Biotech’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Pharmagreen Biotech stock

What is the ROCE (Return on Capital Employed) of Pharmagreen Biotech this year?

The ROCE of Pharmagreen Biotech is 0.22 undefined this year.

How has the ROCE (Return on Capital Employed) of Pharmagreen Biotech developed compared to the previous year?

The ROCE of Pharmagreen Biotech has increased by -63.14% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Pharmagreen Biotech?

A high Return on Capital Employed (ROCE) indicates that Pharmagreen Biotech has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Pharmagreen Biotech?

A low ROCE (Return on Capital Employed) can indicate that Pharmagreen Biotech has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Pharmagreen Biotech impact the company?

An increase in the ROCE of Pharmagreen Biotech can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Pharmagreen Biotech affect the company?

A decrease in ROCE of Pharmagreen Biotech can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Pharmagreen Biotech?

Some factors that can affect Pharmagreen Biotech's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Pharmagreen Biotech so important for investors?

The ROCE of Pharmagreen Biotech is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Pharmagreen Biotech take to improve the ROCE?

To improve the ROCE, Pharmagreen Biotech can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Pharmagreen Biotech pay?

Over the past 12 months, Pharmagreen Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pharmagreen Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Pharmagreen Biotech?

The current dividend yield of Pharmagreen Biotech is .

When does Pharmagreen Biotech pay dividends?

Pharmagreen Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pharmagreen Biotech?

Pharmagreen Biotech paid dividends every year for the past 0 years.

What is the dividend of Pharmagreen Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pharmagreen Biotech located?

Pharmagreen Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharmagreen Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharmagreen Biotech from 1/28/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/28/2025.

When did Pharmagreen Biotech pay the last dividend?

The last dividend was paid out on 1/28/2025.

What was the dividend of Pharmagreen Biotech in the year 2024?

In the year 2024, Pharmagreen Biotech distributed 0 USD as dividends.

In which currency does Pharmagreen Biotech pay out the dividend?

The dividends of Pharmagreen Biotech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pharmagreen Biotech

Our stock analysis for Pharmagreen Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharmagreen Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.